Results 191 to 200 of about 785,437 (225)
Some of the next articles are maybe not open access.
Present status of contraceptive vaginal rings
Advances in Contraception, 1990Vaginal administration of contraceptive steroids has several advantages over oral administration including avoidance of the digestive tract and the 1st passage effect continuous release of the active principle allowing lower doses and fewer side effects independence of the method from sexual relations and possibility of application directly by the user.
R, Jackson +3 more
openaire +2 more sources
Management of the neglected vaginal ring pessary
International Urogynecology Journal, 2006We present two cases of vaginal pessaries left in situ for prolonged periods and subsequent impaction that were managed differently. One was partially epithelialized and removed in the outpatient clinic by a new technique whereby the ring pessary was divided by a bone-cutter and passed through the epithelial tunnel without anesthesia. The second, which
Ruwan J, Fernando +3 more
openaire +2 more sources
Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR)
Contraception, 2007The purpose of this study was to evaluate the in vitro adherence of different yeasts, isolated from vaginal exudates of patients with vulvovaginal candidiasis (VVC), to the combined contraceptive vaginal ring--NuvaRing.Four isolates of Candida sp. and one isolate of Saccharomyces cerevisiae were used.
Daiane Pereira, Camacho +5 more
openaire +2 more sources
Effects of contraceptive vaginal ring treatment on vaginal bacteriology and cytology
Contraception, 1983The presence of aerobic and anaerobic bacteria, yeasts and mycoplasma/ureaplasma was investigated in seventeen women before and after six months use of a contraceptive vaginal ring releasing levo-Norgestrel and estradiol and in 16 women using an oral contraceptive containing levo-Norgestrel and ethinylestradiol. Apart from an increase in yeasts in both
A, Schwan, T, Ahrén, A, Victor
openaire +2 more sources
The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora
Contraception, 1981Premenopausal women seeking a steroid contraceptive method were allowed to choose between a contraceptive vaginal ring (CVR) containing levonorgestrel and estradiol used in a 3-week in, 1-week out regimen (n=20) and an oral contraceptive (OC) containing levonorgestrel and ethinyl estradiol in a 28-day regimen (n = 10).
S, Roy, J, Wilkins, D R, Mishell
openaire +2 more sources
Vaginal Rings for Menopausal Symptom Relief
Drugs & Aging, 2004The vagina is an alternative delivery site of sex steroids for menopausal women. New ring technology provides continuous and consistent delivery of steroids for up to 3 months. Rings rest on the pelvic floor muscles in a nearly horizontal position and are usually imperceptible.
openaire +2 more sources
Update on contraceptive vaginal rings
Reviews in Gynaecological Practice, 2003Abstract Since the development of the combined oral contraceptive pill (OCP) four decades ago, women have been able to plan their childbearing more effectively than before. Studies of women’s attitudes, however, show that many regard the compliance required with daily pill use as a drawback to the use of the oral contraception and would prefer a ...
openaire +1 more source
Vaginal Rings for Contraceptive Use
1999Steroids released from vaginal rings avoid first pass hepatic metabolism, producing high bio-availability. It has long been recognised that drug absorption occurs across the vaginal mucosa (Macht, 1918). The first vaginal ring study was that described by Mishell et al, 1970.
openaire +1 more source